METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Clinical trials for METASTATIC TRIPLE-NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC TRIPLE-NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for METASTATIC TRIPLE-NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a different chemo drug improve outcomes for black caribbean women with aggressive breast cancer?
Disease control Not yet recruitingThis study compares two chemotherapy drugs—gemcitabine and paclitaxel—in 750 Black Caribbean women with metastatic triple-negative breast cancer who have not yet had treatment for their advanced disease. The goal is to see if gemcitabine, typically used later, works better as a f…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: AntiCancer Research Jamaica • Aim: Disease control
Last updated May 26, 2026 10:13 UTC
-
New pill takes on tough breast cancer in first human trial
Disease control Not yet recruitingThis study tests an experimental oral drug called Zn-Telomir in people with advanced or metastatic triple-negative breast cancer that has worsened after other treatments. The trial has two parts: first, finding a safe dose, then checking if the drug can shrink tumors. About 76 ad…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Telomir Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 10:02 UTC
-
New drug combo aims to shrink tumors in Hard-to-Treat breast cancer
Disease control Not yet recruitingThis study tests whether adding a new drug called BEBT-209 to standard chemotherapy can shrink tumors and help people with advanced triple-negative breast cancer live longer. About 446 women aged 18 to 75 with locally advanced or metastatic triple-negative breast cancer will take…
Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE2, PHASE3 • Sponsor: BeBetter Med Inc • Aim: Disease control
Last updated May 22, 2026 13:50 UTC